Great video.Till now I have watched this video 5 times in two days. Finally noted every important thing. It was really a much needed video for me as I got very much perplexed whenever I read about any Pharma company. Keep doing such good work sir.
Your look and your analytical brain game both are simply out of the world collection. I learned a lot, a lot - from you. Thank you sir- one of the best value adding series of TH-cam
This Talk gives 10 times more Better knowledge in compare to B. Pharm 4 years Degree.. usually Pharma professiors do not know atleast 5% of this talk.. colleges more focus on Assignments, exams etc.
Sir it is really really helpful to understand the Pharma sector in and out. Sir, will it be possible to go deeper into R&D and Manufacturing separately.... doesn't matter how long the videos are ....as long as you are delivering your insights - it seems that time has glided by rather too soon
Am aspiring Equity research analyst and the first report i would be making about cipla so to get a glimpse how a pharma company works ? saw your video in top recommendation
Awesome video.. I appreciate the effort that you people have put in to provide this quality content. I am sure that this kind of summarised content is not available in youtube. Its very sad to see that people give millions of views to the videos with title `How I made 1 crore with trading?` and not watching this kind of valuable videos. There kind of videos can be good starting point for the people what wants to learn more about particular sector.
Sir, there is mis-information regarding form 483 Form of 483 is issued after every inspection by US FDA. USFDA specifies its list of observations in form 483. Company submits capa plan answering their response to the USFDA,observations If the regulator is satisfied, it issues NAI certificate if the regulator is satisfied but want to further reinspect it issues VAI If the regulator is not satisfied, it issues OAI status Even after OAI status, medicines can be exported to the US market but if regulator is not satisfied, it issues, warning letter and import alert Signifying ban of drug import from that plant into USA
Amazing video 👍 I usually don't comment on any channel or any of the videos but this video, and channel tooo is worth appreciating 👍👍✨ worth watching ✨ Not even a single second wasted watching this ... Well done !
Great Video. Got essential inputs on what to analyse in a pharma company. In short- video de-jargonises many terms used in pharma concall/analyst reports. Thanks for sharing valuable information
Wow.. this was really well researched and explained in easy terms( considering the complexity of the sector). I only wish some time could have been spent on the chemical ingredients and their manufacturers.
Sir very impressive video. One small correction regarding 483 form. No need to stop production if company receives 483 forms. Should stop production for USA only if you receive Warning Letter from USFDA. You may correct this. Thanks
Zydus life is also big into R&D It is itself doing Pharma 3 clinical trial for its NDA Drug Saroglitizar This drug is approved in India by Indian drug regulators and is among top 10 selling drug brand in india with fast growth and adoption among patients
There is also patent term extension for 5 years after patent expires. Also, exclusivity depends on the drug. whether it is a rare disease drug or normal drug.
One of the best video ever. So nicely explained and in simple words at good pace.... Amazing, please keep creating such videos. Request you to make such videos on speciality chemicals
India contribute only 6% (in terms of money) to USA import in pharmaceutical segment while Germany contribution is 14%. Of course in terms of volume India contributes more but margins are Less.
Most underrated channel in youtube for finance aspirants
As a final year B Pharm student I would say spending 55 minutes is worth it. Amazing analysis. Thank you
Great video.Till now I have watched this video 5 times in two days. Finally noted every important thing. It was really a much needed video for me as I got very much perplexed whenever I read about any Pharma company. Keep doing such good work sir.
Your look and your analytical brain game both are simply out of the world collection. I learned a lot, a lot - from you.
Thank you sir- one of the best value adding series of TH-cam
It seems like you are Pharma domain expert. Very well explained.
Sir, we need banking and hotel industry knowledge as same like this video
This Talk gives 10 times more Better knowledge in compare to B. Pharm 4 years Degree.. usually Pharma professiors do not know atleast 5% of this talk.. colleges more focus on Assignments, exams etc.
I am also pharmacist. Apka pharma value chain ya pharma business ka knowledge acha hai..
Very informative .Thank you so much sir for such a good explanation with examples❤
A very easy to understand breakdown of the complexities. Amazing explanation.
Subah subah uthke dekha
Felt good
Thank u sir. Clearly explained. I didnt know how pharm sector work. Now i knew clear explanation.
Every minute of the video was worth watching.
Thank You Sir, Great Video It real Helped a lot to Undertand Pharma Sector.Every one Must watch it befor investing in Pharma sector.
Best explanation !
Very effective transaction of information on Pharma sector. It is useful to me to select Pharma companies for investment purpose
Excellent sir ji...
Sir please aisi hi ek ayurvedic pharma industry pr video banaye
Excellent video Sir! I am being pharma professional, corelate well.❤
Well researched and presented.. thanks
explained in great detail with all the data and sources
Nice explanation ❤️
I'm a NEET aspirant but still I like to watch these type of video😊
very informative. Bahut badiya
Great knowledge sharing , I think many doctors like me also don't know in such depth knowledge in pharma.
Thanks
Excellent
Realy admire your value chain series
Very well explained for a layma. Especially the terms used in the pharma industry.
Sir it is really really helpful to understand the Pharma sector in and out.
Sir, will it be possible to go deeper into R&D and Manufacturing separately.... doesn't matter how long the videos are ....as long as you are delivering your insights - it seems that time has glided by rather too soon
Expected a reply from you Sir
Wonderful Analysis
Very insightful and useful video sir, please keep uploading such high quality content
Am aspiring Equity research analyst and the first report i would be making about cipla so to get a glimpse how a pharma company works ? saw your video in top recommendation
Sir it was really too much informative video thank you 😊
Your value chain videos are very helpful. Thankyou for making these types of videos for us.❤
Thank you so much for your valuable informations 🙏
Thanks nicely explained
Awesome video..
I appreciate the effort that you people have put in to provide this quality content.
I am sure that this kind of summarised content is not available in youtube.
Its very sad to see that people give millions of views to the videos with title `How I made 1 crore with trading?` and not watching this kind of valuable videos.
There kind of videos can be good starting point for the people what wants to learn more about particular sector.
Absolutely right
Very true !
Sir, there is mis-information regarding form 483
Form of 483 is issued after every inspection by US FDA. USFDA specifies its list of observations in form 483. Company submits capa plan answering their response to the USFDA,observations
If the regulator is satisfied, it issues NAI certificate
if the regulator is satisfied but want to further reinspect it issues VAI
If the regulator is not satisfied, it issues OAI status
Even after OAI status, medicines can be exported to the US market but if regulator is not satisfied, it issues, warning letter and import alert Signifying ban of drug import from that plant into USA
Excellent analysis and presentation in lucid language. Thank you so much 🙏
Amazing video 👍 I usually don't comment on any channel or any of the videos but this video, and channel tooo is worth appreciating 👍👍✨ worth watching ✨
Not even a single second wasted watching this ... Well done !
Very good analysis, with facts and figures presented very effectively.....Thank You
Excellent explanation, one small request sir plz provide ppt
Thanks for giving us amazing knowledge about Pharma sector
Very good analysis sir...thank you 😊
Great Video. Got essential inputs on what to analyse in a pharma company. In short- video de-jargonises many terms used in pharma concall/analyst reports. Thanks for sharing valuable information
Wow.. this was really well researched and explained in easy terms( considering the complexity of the sector). I only wish some time could have been spent on the chemical ingredients and their manufacturers.
Sir very impressive video. One small correction regarding 483 form. No need to stop production if company receives 483 forms. Should stop production for USA only if you receive Warning Letter from USFDA. You may correct this. Thanks
thank you sir for your valuable information
Great video
Great video sir,well explained thanku sir
Wonderful session sir
Sir please we need more videos on pharma marketing❤
Great Video. Simple to understand .
Excellent presentation
Zydus life is also big into R&D
It is itself doing Pharma 3 clinical trial for its NDA Drug Saroglitizar
This drug is approved in India by Indian drug regulators and is among top 10 selling drug brand in india with fast growth and adoption among patients
Great Pharma teacher
Excellent job, thank you and kudos for your efforts❤
Gaurav Brilliant 👏 👌
So detailed... Thank you
Very informative video. ...A matured channel.
Gained from ur presentation 👍🏼
Awesome discussion 👏 👌 👍
What a informative video❤
very interesting topic sir ..
Excellent video . Cleared concept
This is a very useful video.
Thank you sir for such amazing information..😊
Good evening sir.. I love your analysis very much..
Thank you
Sir kindly make a playlist of value chain analysis
amazing
Excellent research sir
Thanks a lot
Fantastic - very good coverage in all ways
Awesome
So much interesting more then movie, wow
Great Video. Indepth analysis. Keep it up.
Very good presentation but problem is to get the data
Excellent analysis
Great
There is also patent term extension for 5 years after patent expires.
Also, exclusivity depends on the drug. whether it is a rare disease drug or normal drug.
Sir very useful information.
Very good video have ever seen.
Give it name master class
It was very informative.
Thank you gaurav sir
Great video, thanks for making it.
THANK YOU SO MUCH SIR
very nice video...use markers in ppt
Thank you for enhancing our knowledge ❤
😊😊
One of the best video ever. So nicely explained and in simple words at good pace.... Amazing, please keep creating such videos.
Request you to make such videos on speciality chemicals
Thank you
Great effort
India contribute only 6% (in terms of money) to USA import in pharmaceutical segment while Germany contribution is 14%. Of course in terms of volume India contributes more but margins are Less.
Thank you sir 🙏
Please give information information about USA Pharma company 🙏
Great effort 💯 👍🎉
Please refer the best company to buy now
Ipca, cipla, sun, aurobindo, divis lab , alkem
Sir please do IT sector analysis
Very good
Next value chain konsi karenge???
Can you turn allow the access to the English subtitles
What valuation multiple should be ideal for domestic as well as global pharma indian co